Staar Surgical [STAA] vs Intuitive Surgical [ISRG] Detailed Stock Comparison
Staar Surgical
NASDAQ
Loading...
Intuitive Surgical
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Staar Surgical wins in 8 metrics, Intuitive Surgical wins in 10 metrics, with 0 ties. Intuitive Surgical appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Staar Surgical | Intuitive Surgical | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 49.73 | 63.00 | Staar Surgical |
| Price-to-Book Ratio | 3.97 | 9.08 | Staar Surgical |
| Debt-to-Equity Ratio | 12.04 | 0.00 | Intuitive Surgical |
| PEG Ratio | -0.15 | 2.59 | Staar Surgical |
| EV/EBITDA | -16.38 | 49.26 | Staar Surgical |
| Profit Margin (TTM) | -42.45% | 28.51% | Intuitive Surgical |
| Operating Margin (TTM) | -55.63% | 30.47% | Intuitive Surgical |
| EBITDA Margin (TTM) | N/A | 30.47% | N/A |
| Return on Equity | -25.55% | 16.04% | Intuitive Surgical |
| Return on Assets (TTM) | -10.71% | 9.02% | Intuitive Surgical |
| Free Cash Flow (TTM) | $-7.67M | $1.30B | Intuitive Surgical |
| 1-Year Return | -15.12% | -7.24% | Intuitive Surgical |
| Price-to-Sales Ratio (TTM) | 5.97 | 17.73 | Staar Surgical |
| Enterprise Value | $1.20B | $156.94B | Intuitive Surgical |
| EV/Revenue Ratio | 5.33 | 17.16 | Staar Surgical |
| Gross Profit Margin (TTM) | 74.00% | 66.31% | Staar Surgical |
| Revenue per Share (TTM) | $5 | $26 | Intuitive Surgical |
| Earnings per Share (Diluted) | $-1.93 | $7.18 | Intuitive Surgical |
| Beta (Stock Volatility) | 0.83 | 1.61 | Staar Surgical |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Staar Surgical vs Intuitive Surgical Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Staar Surgical | -1.14% | -0.07% | -3.11% | 61.53% | 66.23% | 11.33% |
| Intuitive Surgical | -0.59% | 2.38% | -4.32% | -15.90% | -3.00% | -14.19% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Staar Surgical | -15.12% | -61.10% | -55.58% | 209.82% | 380.82% | 402.43% |
| Intuitive Surgical | -7.24% | 145.65% | 79.24% | 765.95% | 1,346.41% | 5,952.36% |
News Based Sentiment: Staar Surgical vs Intuitive Surgical
Staar Surgical
News based Sentiment: NEGATIVE
October was a pivotal month for STAAR Surgical, marked by significant opposition to the Alcon merger from a major shareholder and ongoing legal scrutiny. While regulatory hurdles have been cleared, the deal's future is far from certain, creating substantial risk for investors and overshadowing the company's challenging Q2 financial results.
Intuitive Surgical
News based Sentiment: POSITIVE
Intuitive Surgical demonstrated strong financial performance in Q2 2025, coupled with significant product innovation and regulatory approvals. While analyst price targets were mixed, the overall sentiment remains positive, supported by a 'Moderate Buy' consensus and increased institutional holdings, suggesting continued growth potential.
Performance & Financial Health Analysis: Staar Surgical vs Intuitive Surgical
| Metric | STAA | ISRG |
|---|---|---|
| Market Information | ||
| Market Cap | $1.36B | $163.30B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 667,385 | 2,417,000 |
| 90 Day Avg. Volume | 717,495 | 2,455,233 |
| Last Close | $26.83 | $449.69 |
| 52 Week Range | $13.50 - $35.39 | $425.00 - $616.00 |
| % from 52W High | -24.19% | -27.00% |
| All-Time High | $163.08 (Sep 06, 2021) | $616.00 (Jan 20, 2025) |
| % from All-Time High | -83.55% | -27.00% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.55% | 0.21% |
| Quarterly Earnings Growth | -0.55% | 0.25% |
| Financial Health | ||
| Profit Margin (TTM) | -0.42% | 0.29% |
| Operating Margin (TTM) | -0.56% | 0.30% |
| Return on Equity (TTM) | -0.26% | 0.16% |
| Debt to Equity (MRQ) | 12.04 | 0.00 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $6.83 | $49.79 |
| Cash per Share (MRQ) | $3.83 | $14.86 |
| Operating Cash Flow (TTM) | $-28,525,000 | $2.83B |
| Levered Free Cash Flow (TTM) | $6.41M | $1.82B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Staar Surgical vs Intuitive Surgical
| Metric | STAA | ISRG |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 49.73 | 63.00 |
| Forward P/E | 34.35 | 57.55 |
| PEG Ratio | -0.15 | 2.59 |
| Price to Sales (TTM) | 5.97 | 17.73 |
| Price to Book (MRQ) | 3.97 | 9.08 |
| Market Capitalization | ||
| Market Capitalization | $1.36B | $163.30B |
| Enterprise Value | $1.20B | $156.94B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 5.33 | 17.16 |
| Enterprise to EBITDA | -16.38 | 49.26 |
| Risk & Other Metrics | ||
| Beta | 0.83 | 1.61 |
| Book Value per Share (MRQ) | $6.83 | $49.79 |
Financial Statements Comparison: Staar Surgical vs Intuitive Surgical
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | STAA | ISRG |
|---|---|---|
| Revenue/Sales | $42.59M | $2.44B |
| Cost of Goods Sold | $14.58M | $822.10M |
| Gross Profit | $28.01M | $1.62B |
| Research & Development | $13.66M | $313.30M |
| Operating Income (EBIT) | $-34.74M | $743.40M |
| EBITDA | $-11.15M | $898.70M |
| Pre-Tax Income | $-54.49M | $832.10M |
| Income Tax | $-275,000 | $167.90M |
| Net Income (Profit) | $-54.21M | $664.20M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | STAA | ISRG |
|---|---|---|
| Cash & Equivalents | $173.11M | $2.57B |
| Total Current Assets | $326.50M | $7.66B |
| Total Current Liabilities | $68.36M | $1.54B |
| Long-Term Debt | $33.12M | N/A |
| Total Shareholders Equity | $349.97M | $17.21B |
| Retained Earnings | $-121.79M | $7.14B |
| Property, Plant & Equipment | $865,000 | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | STAA | ISRG |
|---|---|---|
| Operating Cash Flow | $-15.68M | $833.10M |
| Capital Expenditures | $-1.47M | $-116.60M |
| Free Cash Flow | $-7.20M | $465.00M |
| Debt Repayment | $-42,000 | N/A |
| Common Stock Repurchase | $-1.28M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | STAA | ISRG |
|---|---|---|
| Shares Short | 3.89M | 5.72M |
| Short Ratio | 5.51 | 2.50 |
| Short % of Float | 0.14% | 0.02% |
| Average Daily Volume (10 Day) | 667,385 | 2,417,000 |
| Average Daily Volume (90 Day) | 717,495 | 2,455,233 |
| Shares Outstanding | 49.29M | 356.60M |
| Float Shares | 27.37M | 356.30M |
| % Held by Insiders | 0.01% | 0.01% |
| % Held by Institutions | 1.10% | 0.89% |
Dividend Analysis & Yield Comparison: Staar Surgical vs Intuitive Surgical
| Metric | STAA | ISRG |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |